Literature DB >> 15466989

Gene therapy in clinical medicine.

S M Selkirk1.   

Abstract

Although the field of gene therapy has experienced significant setbacks and limited success, it is one of the most promising and active research fields in medicine. Interest in this therapeutic modality is based on the potential for treatment and cure of some of the most malignant and devastating diseases affecting humans. Over the next decade, the relevance of gene therapy to medical practices will increase and it will become important for physicians to understand the basic principles and strategies that underlie the therapeutic intervention. This report reviews the history, basic strategies, tools, and several current clinical paradigms for application.

Entities:  

Mesh:

Year:  2004        PMID: 15466989      PMCID: PMC1743106          DOI: 10.1136/pgmj.2003.017764

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  149 in total

1.  Nanoparticles of compacted DNA transfect postmitotic cells.

Authors:  Ge Liu; DeShan Li; Murali K Pasumarthy; Tomasz H Kowalczyk; Christopher R Gedeon; Susannah L Hyatt; Jennifer M Payne; Timothy J Miller; Peter Brunovskis; Tamara L Fink; Osman Muhammad; Robert C Moen; Richard W Hanson; Mark J Cooper
Journal:  J Biol Chem       Date:  2003-06-14       Impact factor: 5.157

2.  Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats.

Authors:  Y Ikeda; Y Goto; Y Yonemitsu; M Miyazaki; T Sakamoto; T Ishibashi; T Tabata; Y Ueda; M Hasegawa; S Tobimatsu; K Sueishi
Journal:  Gene Ther       Date:  2003-07       Impact factor: 5.250

3.  Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

Authors:  Frederick F Lang; Janet M Bruner; Gregory N Fuller; Kenneth Aldape; Michael D Prados; Susan Chang; Mitchel S Berger; Michael W McDermott; Sandeep M Kunwar; Larry R Junck; William Chandler; James A Zwiebel; Richard S Kaplan; W K Alfred Yung
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

4.  Growth-factor gene therapy for neurodegenerative disorders.

Authors:  Mark H Tuszynski
Journal:  Lancet Neurol       Date:  2002-05       Impact factor: 44.182

5.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

Review 6.  Why did p53 gene therapy fail in ovarian cancer?

Authors:  Alain G Zeimet; Christian Marth
Journal:  Lancet Oncol       Date:  2003-07       Impact factor: 41.316

7.  Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Authors:  Terence R Flotte; Pamela L Zeitlin; Thomas C Reynolds; Alison E Heald; Patty Pedersen; Suzanne Beck; Carol K Conrad; Lois Brass-Ernst; Margaret Humphries; Kevin Sullivan; Randall Wetzel; George Taylor; Barrie J Carter; William B Guggino
Journal:  Hum Gene Ther       Date:  2003-07-20       Impact factor: 5.695

8.  Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells.

Authors:  Michal Zalzman; Sanjeev Gupta; Ranjit K Giri; Irina Berkovich; Baljit S Sappal; Ohad Karnieli; Mark A Zern; Norman Fleischer; Shimon Efrat
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

Review 9.  Early diagnosis of Alzheimer's disease: clinical and economic benefits.

Authors:  Bennett P Leifer
Journal:  J Am Geriatr Soc       Date:  2003-05       Impact factor: 5.562

Review 10.  Safety of adeno-associated virus gene therapy vectors: a current evaluation.

Authors:  Paul E Monahan; Karin Jooss; Mark S Sands
Journal:  Expert Opin Drug Saf       Date:  2002-05       Impact factor: 4.250

View more
  11 in total

Review 1.  Engineering biomaterial systems to enhance viral vector gene delivery.

Authors:  Jae-Hyung Jang; David V Schaffer; Lonnie D Shea
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

2.  Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery.

Authors:  J-H Jang; J T Koerber; K Gujraty; S R Bethi; R S Kane; D V Schaffer
Journal:  Gene Ther       Date:  2010-05-27       Impact factor: 5.250

3.  Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.

Authors:  Balaji Krishnamachary; Kristine Glunde; Flonne Wildes; Noriko Mori; Tomoyo Takagi; Venu Raman; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

Review 4.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

5.  Characterization of nanoparticle mediated laser transfection by femtosecond laser pulses for applications in molecular medicine.

Authors:  Markus Schomaker; Dag Heinemann; Stefan Kalies; Saskia Willenbrock; Siegfried Wagner; Ingo Nolte; Tammo Ripken; Hugo Murua Escobar; Heiko Meyer; Alexander Heisterkamp
Journal:  J Nanobiotechnology       Date:  2015-02-03       Impact factor: 10.435

Review 6.  Electrospun nanofibers as versatile interfaces for efficient gene delivery.

Authors:  Slgirim Lee; Gyuhyung Jin; Jae-Hyung Jang
Journal:  J Biol Eng       Date:  2014-12-09       Impact factor: 4.355

Review 7.  Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System.

Authors:  Sara Artusi; Yoshitaka Miyagawa; William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Diseases       Date:  2018-08-14

8.  A preliminary step of a novel strategy in suicide gene therapy with lentiviral vector.

Authors:  Jahan Afrooz Ghanbari; Mansoor Salehi; Arezoo Karam Zadeh; Sedigheh Momen Zadeh; Vahid Bahram Beigi; Hossein Khan Ahmad; Behzad Mahaki; Mina Beiraghdar
Journal:  Adv Biomed Res       Date:  2014-01-09

9.  CAPN5 gene silencing by short hairpin RNA interference.

Authors:  Nnamdi G Nelson; Jessica M Skeie; Hakim Muradov; Hannah A Rowell; Seongjin Seo; Vinit B Mahajan
Journal:  BMC Res Notes       Date:  2014-09-12

Review 10.  Exploitation of viral properties for intracellular delivery.

Authors:  Stefania Galdiero; Annarita Falanga; Mariateresa Vitiello; Paolo Grieco; Michele Caraglia; Giancarlo Morelli; Massimiliano Galdiero
Journal:  J Pept Sci       Date:  2014-05-30       Impact factor: 1.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.